NCI mulls genetic risk of prostate, breast cancer

June 3, 2006

Future cancer management may rely on identifying healthy individuals at risk before they develop symptoms of disease, according to National Cancer Institute researchers.

Future cancer management may rely on identifying healthy individuals at risk before they develop symptoms of disease, according to National Cancer Institute researchers.

The NCI has launched an initiative to identify genetic alterations that create susceptibility to prostate and breast cancer. The three-year, $14 million Cancer Genetic Markers of Susceptibility project will begin by scanning 2500 genetic samples from men who have been diagnosed with prostate cancer as well as a control group. Data will be available via the NCI.